Jennifer Good is co-founder, President and CEO of Trevi Therapeutics, Inc. Previously, Ms. Good served at Penwest Pharmaceuticals, where she held various positions including President and CEO, COO and CFO. Ms. Good currently serves on the board of Rhythm Pharmaceuticals, Inc. Ms. Good previously served on the board of Juniper Pharmaceuticals, Inc., from September 2017 until it was acquired in August 2018. Ms. Good currently serves as a board member of the Friedreich’s Ataxia Research Alliance (FARA), she is the Treasurer for a non-profit organization, Newtown Youth and Family Services, a board member of the newly-formed Executive Women in Bio, CT Chapter and a Co-Chair of the New Haven Regional Bioscience Collaborative. Ms. Good received a Bachelor of Business Administration degree with a concentration in accounting from Pacific Lutheran University in 1987 and is a Certified Public Accountant licensed by the State of Washington, although her license is currently inactive.